GlobeNewswire - Industry News on Consumer Services

Have You Lost Money Investing In Athenex, Inc. Securities? – Kehoe Law Firm, P.C. Class Action Investigation On Behalf Of ATNX Investors Who Have Suffered Losses Greater Than $50,000

Tue, 02 Mar 2021 01:29 GMT

PHILADELPHIA, March 01, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) to determine whether the Company engaged in securities fraud or other unlawful business practices.

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline – EH

Tue, 02 Mar 2021 01:00 GMT

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of EHang Holdings Limited (NASDAQ: EH) between December 12, 2019 and February 16, 2021, inclusive (the “Class Period”), of the important April 19, 2021 lead plaintiff deadline.

Aerospace Adhesives & Sealants Market Size to Worth Around US$ 1.55 Billion by 2027

Tue, 02 Mar 2021 01:00 GMT

Precedence Research, Recently Published Report on “Aerospace Adhesives & Sealants Market Size, Share, Growth, Trends, Segmentation and Forecast 2020 - 2027”.

ROSEN, A TOP RANKED LAW FIRM, Files Securities Class Action Lawsuit on Behalf of MoneyGram International, Inc. Investors; Encourages Investors With Losses Over $100K to Secure Counsel Before Important Deadline – MGI

Tue, 02 Mar 2021 00:40 GMT

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- WHY:?Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of MoneyGram International, Inc. (NASDAQ: MGI) between June 17, 2019 and February 22, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021.

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed against MultiPlan Corporation – MPLN; MPLN.WS

Tue, 02 Mar 2021 00:11 GMT

RADNOR, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against MultiPlan Corporation (NYSE: MPLN; MPLN.WS) (“MultiPlan”) f/k/a Churchill Capital Corp. III (“Churchill III”) on behalf of: (1) those who purchased or acquired MultiPlan securities between July 12, 2020 and November 10, 2020, inclusive (the “Class Period”); and (2) all holders of Churchill III Class A common stock entitled to vote on Churchill III’s merger with and acquisition of Polaris Parent Corp. and its consolidated subsidiaries consummated in October 2020 (the “Merger”).

Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA? - New Innovative Treatment for Irritable Bowel Syndrome with Constipation

Tue, 02 Mar 2021 00:04 GMT

MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today the Canadian commercial availability of IBSRELA (tenapanor), a first-in-class therapy for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Knight has the exclusive right to commercialize IBSRELA in Canada under the terms of a license agreement entered into with Ardelyx, Inc. (NASDAQ: ARDX) in March 2018, which license agreement also provides Knight with exclusive rights to commercialize tenapanor for hyperphosphatemia in Canada.?? IBSRELA was approved by Health Canada on April 15, 2020 and is now covered by most private insurance companies in Canada.

Thérapeutique Knight annonce le lancement commercial canadien de IBSRELA(MC) — un nouveau traitement innovant du syndrome de c?lon irritable avec constipation

Tue, 02 Mar 2021 00:04 GMT

MONTRÉAL, 01 mars 2021 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (??Knight??), société pharmaceutique spécialisée panaméricaine (ex-éU), a annoncé aujourd’hui la mise en marché au Canada de IBSRELA (tenapanor), thérapie de pointe pour le traitement du syndrome du c?lon irritable avec constipation (SCI-C) chez les adultes. Knight détient le droit exclusif de commercialisation de IBSRELA selon les modalités d’une entente de licence conclue avec Ardelyx, Inc. (NASDAQ : ARDX) en mars 2018, une entente de licence qui octroie également à Knight l’exclusivité des droits de commercialisation de tenapanor pour l’hyperphosphatémie au Canada. IBSRELA a été approuvé par Santé Canada en date du 15?avril 2020 et est désormais couvert par la majorité des compagnies d’assurance privées au Canada.

Automotive Lightweight Materials Market Size to Hit US$ 115.37 Bn by 2027

Tue, 02 Mar 2021 00:00 GMT

The automotive lightweight materials market size is expected to hit over US$ 115.37 billion by 2027 with a CAGR of 7.4%, according to new report by Precedence Research.

The automotive lightweight materials market size is expected to hit over US$ 115.37 billion by 2027 with a CAGR of 7.4%, according to new report by Precedence Research.

Spinal Fusion Devices Market Size Worth USD 8.90 Billion by 2027 | The Advancements in Surgical Technology and Rising Demand for Minimally Invasive Spine Surgeries are Significant Factors Influencing Industry Growth, says Emergen Research

Tue, 02 Mar 2021 00:00 GMT

Key participants in Spinal Fusion Devices market include B. Braun Melsungen, Alphatec Holdings, Inc., Exactech, Inc., DePuy Synthes Companies (Johnson & Johnson Services, Inc.), Medtronic PLC, Globus Medical, Inc., NuVasive, Inc., Stryker Corporation, Orthofix International N.V., and Zimmer Biomet Holdings, Inc., among others.

Key participants in Spinal Fusion Devices market include B. Braun Melsungen, Alphatec Holdings, Inc., Exactech, Inc., DePuy Synthes Companies (Johnson & Johnson Services, Inc.), Medtronic PLC, Globus Medical, Inc., NuVasive, Inc., Stryker Corporation, Orthofix International N.V., and Zimmer Biomet Holdings, Inc., among others.

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Class Action Lawsuit Against Bit Digital, Inc. (BTBT)

Mon, 01 Mar 2021 23:41 GMT

RADNOR, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Bit Digital, Inc. (NASDAQ: BTBT) (“Bit Digital”) on behalf of those who purchased or acquired Bit Digital securities between December 21, 2020 and January 8, 2021, inclusive (the “Class Period”).

SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate WIFI, CHNG, CUB, VIE; Shareholders Are Encouraged to Contact the Firm

Mon, 01 Mar 2021 23:28 GMT

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

ROSEN, A TOP RANKED FIRM, Encourages fuboTV Inc. Investors With Large Losses to Secure Counsel Before Important Deadline – FUBO

Mon, 01 Mar 2021 23:23 GMT

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of fuboTV Inc. (NYSE: FUBO) between March 23, 2020 and January 4, 2021, inclusive (the “Class Period”), of the important April 19, 2021 lead plaintiff deadline.

Emerson Firm, PLLC Announces Ongoing Investigation Involving Nissan Pathfinder

Mon, 01 Mar 2021 23:18 GMT

HOUSTON, March 01, 2021 (GLOBE NEWSWIRE) -- Emerson Firm, PLLC announces a continuing investigation of a hugely significant issue involving the transmission system of Nissan Pathfinder vehicles. This matter relates to consumers who purchased or leased any 2015 through the present Nissan Pathfinder.? ??

Saxena White P.A., The Only Law Firm That Filed A Securities Fraud Class Action On Behalf Of Investors In Penumbra Inc. Common Stock, Reminds Investors That There is Limited Time to File a Motion for Lead Plaintiff Appointment

Mon, 01 Mar 2021 23:14 GMT

PEN Investor Filing Deadline: Saxena White P.A., the Only Law Firm that Filed a Securities Fraud Class Action Against Penumbra Inc. Arising Out of the Company’s Misrepresentations to Investors Regarding the Jet 7 Xtra Flex Aspiration Catheter, Reminds Investors that the Statutory Deadline to File a Motion for Lead Plaintiff Status is March 16, 2021

Immunotherapy Drugs Market Size to Reach USD 365.57 Billion by 2027 | Rising Advent of Biologics and Increasing Demand for Monoclonal Antibodies are Significant Factors Influencing Industry Growth, says Emergen Research

Mon, 01 Mar 2021 23:00 GMT

Key Immunotherapy Drugs market participants include Sanofi S.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., AstraZeneca plc, BioNTech SE, Gilead Sciences, Inc., Incyte Corporation, bluebird bio, Inc., and Genmab A/S, Bayer AG

Key Immunotherapy Drugs market participants include Sanofi S.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., AstraZeneca plc, BioNTech SE, Gilead Sciences, Inc., Incyte Corporation, bluebird bio, Inc., and Genmab A/S, Bayer AG

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

Mon, 01 Mar 2021 23:00 GMT

WINNIPEG, Manitoba, March 01, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to announce that it has completed its final services milestone under an agreement with Ontario based Micro Cultivation partner, F1NE Cannabis Cultivation LTD. (“F1”). F1 is an arm’s length third party in which the Company has no ownership control or interest.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds AstraZeneca (AZN) Investors of Pending Securities Class Action, Encourages Investors Who Suffered Losses to Contact the Firm

Mon, 01 Mar 2021 22:35 GMT

SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now.?A securities fraud class action has been filed and certain investors may have valuable claims.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Ebix (EBIX) Investors to Contact the Firm Now, Securities Fraud Case Filed After Auditor Quits Due to “Significant Unusual Transactions”

Mon, 01 Mar 2021 22:30 GMT

SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ebix, Inc. (NASDAQ: EBIX) investors with significant losses to submit your losses now. A securities fraud class action has been filed and certain investors may have valuable claims.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Bit Digital (BTBT) Investors to Securities Fraud Lawsuit, Encourages Investors with Significant Losses to Contact the Firm Now

Mon, 01 Mar 2021 22:27 GMT

SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in Bit Digital, Inc. (NASDAQ: BTBT) with significant losses submit your losses now. A securities fraud class action has been filed and certain investors may have valuable claims.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts EHang Holdings Limited (EH) Investors to Securities Fraud Class Action and Invites Investors with Losses to Contact the Firm

Mon, 01 Mar 2021 22:23 GMT

SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges EHang Holdings Limited (NASDAQ: EH) investors with significant losses to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.